Asia-Pacific property and retail group Metro Holdings through its subsidiary Metro ARC Investments is buying a 10% interest in DocMed, the digital health arm of Singaporean consumer healthcare group Hyphens Pharma, for SG$6 million ($4.3 million).
The investment will represent a Series A funding for DocMed, later raising its valuation to SG$60 million ($43.5 million) based on the subscription...
Specialty pharmaceutical and consumer healthcare company Hyphens Pharma has formally launched Singapore's first Health Sciences Authority-approved digital pharmacy.
WHAT IT DOES
Hyphens Pharma is engaged in three business segments: specialty pharma, proprietary brands, and medical hypermart and digital. It has established its presence across major Southeast Asian countries, including Singapore,...
